ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,066,000 | +5.0% | 2,496,297 | -14.5% | 0.72% | -2.9% |
| Q2 2022 | $5,778,000 | -38.5% | 2,918,260 | -43.2% | 0.75% | -30.9% |
| Q1 2022 | $9,402,000 | +5.0% | 5,137,857 | -19.1% | 1.08% | +9.9% |
| Q4 2021 | $8,954,000 | +959.6% | 6,350,694 | +749.7% | 0.98% | +1130.0% |
| Q3 2021 | $845,000 | -42.8% | 747,445 | -19.0% | 0.08% | -63.6% |
| Q2 2021 | $1,476,000 | +140.8% | 922,517 | +165.0% | 0.22% | +175.0% |
| Q1 2021 | $613,000 | – | 348,078 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |